Spots Global Cancer Trial Database for total body irradiation (tbi)
Every month we try and update this database with for total body irradiation (tbi) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| BuCY vs TBICY Conditioning Regimen for Standard-risk ALL Undergoing Allo-HSCT | NCT02670252 | Allogeneic Hema... Busulfan Total Body Irra... Acute Lymphocyt... | Busulfan (BU) Cyclophosphamid... Total Body Irra... | 14 Years - 65 Years | Nanfang Hospital, Southern Medical University | |
| Randomized Double Cord Blood Transplant Study | NCT00067002 | Leukemia, Lymph... Leukemia, Myelo... Leukemia, Myelo... Lymphoma, Non-H... | Expanded alloge... One Unmanipulat... Rituxan Melphalan Thiotepa Fludarabine Cyclophosphamid... Mesna Total body irra... | 1 Month - 80 Years | M.D. Anderson Cancer Center | |
| Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML) | NCT02441803 | Leukemia | Busulfan Fludarabine Clofarabine Total Body Irra... Thymoglobulin Stem Cell Infus... Cyclophosphamid... Tacrolimus Mycophenolate m... Decitabine Cytarabine Idarubicin | 18 Years - 60 Years | M.D. Anderson Cancer Center | |
| Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies | NCT04959175 | Hematologic Neo... | Mycophenolate M... Allogeneic HSCT Fludarabine Sirolimus Filgrastim Cyclophosphamid... Mesna Total Body Irra... | 12 Years - 85 Years | National Institutes of Health Clinical Center (CC) | |
| A Two-Step Approach to Bone Marrow Transplant Using Cells From A Partially-Matched Relative | NCT00429143 | Hematologic Mal... | Total Body Irra... Donor Lymphocyt... Cyclophosphamid... Tacrolimus Mycophenolate M... Hematopoietic S... | 18 Years - | Thomas Jefferson University | |
| Cord Blood Transplantation for Patients With Cancer | NCT01359254 | Hematological D... | Melphalan Fludarabine Antithymocyte G... Busulfan Total Body Irra... | 18 Years - | University of Chicago | |
| CD34+ Transplants for Leukemia and Lymphoma | NCT05565105 | Leukemia, Myelo... Leukemia, Lymph... | Total Body Irra... Thiotepa Cyclophosphamid... Busulfan Melphalan Fludarabine | 18 Years - 74 Years | Baptist Health South Florida | |
| Bone Marrow Transplantation in Treating Patients With Chronic Lymphocytic Leukemia | NCT00002844 | Leukemia | Cyclophosphamid... Allogeneic Bone... Autologous Bone... Total Body Irra... | 16 Years - 65 Years | M.D. Anderson Cancer Center | |
| Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies | NCT01471067 | Blood And Marro... Leukemia Lymphoma Transplantation... Transplantation... | Melphalan Fludarabine Mycophenolate m... Tacrolimus Cord Blood Infu... Rituximab ATG Busulfan Clofarabine Total Body Irra... | 1 Year - 80 Years | M.D. Anderson Cancer Center | |
| Bone Marrow Transplantation in Treating Patients With Chronic Lymphocytic Leukemia | NCT00002844 | Leukemia | Cyclophosphamid... Allogeneic Bone... Autologous Bone... Total Body Irra... | 16 Years - 65 Years | M.D. Anderson Cancer Center | |
| Infusion of Expanded Cord Blood T Cells | NCT00972101 | Stem Cell Trans... Leukemia Lymphoma Pediatric Disor... | Total Body Irra... Melphalan Thiotepa Fludarabine Rituximab Etoposide Anti-thymocyte ... Mycophenolate M... Tacrolimus Cord Blood Infu... G-CSF Ex vivo expande... | - 55 Years | M.D. Anderson Cancer Center | |
| Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation | NCT03734601 | Acute Myeloid L... Myelodysplastic... Myeloproliferat... Chronic Lymphoc... B-cell Lymphoma T-cell Lymphoma Non Hodgkin Lym... Hodgkin Lymphom... Chronic Myelomo... | Total body irra... Anti-thymocyte ... Tacrolimus Mycophenolate m... Total lymphoid ... | 18 Years - | Stanford University | |
| Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor | NCT01350245 | Acute Myeloid L... Myelodysplastic... Biphenotypic Le... Acute Lymphocyt... Chronic Myeloid... Chronic Lymphoc... Plasma Cell Neo... Lymphoma Hodgkin's Disea... Aplastic Anemia | Total Body Irra... Donor Lymphocyt... Cyclophosphamid... Mycophenolate M... Tacrolimus Hematopoietic s... | 18 Years - | Thomas Jefferson University | |
| Flu,Alemtuzumab,and TBI Followed By Donor Stem Cell Chronic Phase CML | NCT00416884 | Leukemia | Campath Fludarabine Total Body Irra... T-Cell Deplete | 4 Years - 75 Years | OHSU Knight Cancer Institute | |
| Clofarabine Pre-conditioning Followed by Stem Cell Transplant for Non-remission AML | NCT04002115 | Acute Myeloid L... | Clofarabine Fludarabine Busulfan Total Body Irra... Cyclophosphamid... Granulocyte Col... Tacrolimus Cellcept | 18 Years - 55 Years | Milton S. Hershey Medical Center | |
| Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation | NCT03734601 | Acute Myeloid L... Myelodysplastic... Myeloproliferat... Chronic Lymphoc... B-cell Lymphoma T-cell Lymphoma Non Hodgkin Lym... Hodgkin Lymphom... Chronic Myelomo... | Total body irra... Anti-thymocyte ... Tacrolimus Mycophenolate m... Total lymphoid ... | 18 Years - | Stanford University | |
| Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies | NCT04959175 | Hematologic Neo... | Mycophenolate M... Allogeneic HSCT Fludarabine Sirolimus Filgrastim Cyclophosphamid... Mesna Total Body Irra... | 12 Years - 85 Years | National Institutes of Health Clinical Center (CC) | |
| Umbilical Cord Blood Transplant for Children With Lymphoid Hematological Malignancies | NCT01247688 | Lymphoid Hemato... Umbilical Cord ... | Cytoxan Fludarabine Total Body Irra... Cord Blood Stem... | - | Baylor College of Medicine | |
| Prospective Randomized Study of Cell Transfer Therapy for Metastatic Melanoma Using Tumor Infiltrating Lymphocytes Plus IL-2 Following Non-Myeloablative Lymphocyte Depleting Chemo Regimen Alone or in Conjunction With 12Gy Total Body Irradiation (TBI... | NCT01319565 | Metastatic Mela... Skin Cancer | Aldesleukin Cyclophosphamid... Fludarabine Young TIL Total Body Irra... | 18 Years - 66 Years | National Institutes of Health Clinical Center (CC) | |
| Cord Blood Transplantation for Patients With Cancer | NCT01359254 | Hematological D... | Melphalan Fludarabine Antithymocyte G... Busulfan Total Body Irra... | 18 Years - | University of Chicago | |
| Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML) | NCT02441803 | Leukemia | Busulfan Fludarabine Clofarabine Total Body Irra... Thymoglobulin Stem Cell Infus... Cyclophosphamid... Tacrolimus Mycophenolate m... Decitabine Cytarabine Idarubicin | 18 Years - 60 Years | M.D. Anderson Cancer Center | |
| T-Reg Cell Kinetics, Stem Cell Transplant, REGALE | NCT00578539 | Leukemia Hodgkin Lymphom... Non Hodgkin Lym... Myeloproliferat... | ARA C Cyclophosphamid... MESNA Total Body Irra... Campath-1h Stem Cell Infus... | - | Baylor College of Medicine | |
| T-Reg Cell Kinetics, Stem Cell Transplant, REGALE | NCT00578539 | Leukemia Hodgkin Lymphom... Non Hodgkin Lym... Myeloproliferat... | ARA C Cyclophosphamid... MESNA Total Body Irra... Campath-1h Stem Cell Infus... | - | Baylor College of Medicine | |
| Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation | NCT03734601 | Acute Myeloid L... Myelodysplastic... Myeloproliferat... Chronic Lymphoc... B-cell Lymphoma T-cell Lymphoma Non Hodgkin Lym... Hodgkin Lymphom... Chronic Myelomo... | Total body irra... Anti-thymocyte ... Tacrolimus Mycophenolate m... Total lymphoid ... | 18 Years - | Stanford University | |
| Stem Cell Transplant for Hematologic Diseases | NCT00058825 | Hematologic Mal... | Campath 1H Fludarabine Stem Cell Trans... Total Body Irra... FK506 (Tacrolim... | - 70 Years | Baylor College of Medicine | |
| Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies | NCT01471067 | Blood And Marro... Leukemia Lymphoma Transplantation... Transplantation... | Melphalan Fludarabine Mycophenolate m... Tacrolimus Cord Blood Infu... Rituximab ATG Busulfan Clofarabine Total Body Irra... | 1 Year - 80 Years | M.D. Anderson Cancer Center | |
| T-Reg Cell Kinetics, Stem Cell Transplant, REGALE | NCT00578539 | Leukemia Hodgkin Lymphom... Non Hodgkin Lym... Myeloproliferat... | ARA C Cyclophosphamid... MESNA Total Body Irra... Campath-1h Stem Cell Infus... | - | Baylor College of Medicine | |
| Clofarabine Pre-conditioning Followed by Stem Cell Transplant for Non-remission AML | NCT04002115 | Acute Myeloid L... | Clofarabine Fludarabine Busulfan Total Body Irra... Cyclophosphamid... Granulocyte Col... Tacrolimus Cellcept | 18 Years - 55 Years | Milton S. Hershey Medical Center | |
| Stem Cell Transplant for Hematologic Diseases | NCT00058825 | Hematologic Mal... | Campath 1H Fludarabine Stem Cell Trans... Total Body Irra... FK506 (Tacrolim... | - 70 Years | Baylor College of Medicine | |
| Infusion of Expanded Cord Blood T Cells | NCT00972101 | Stem Cell Trans... Leukemia Lymphoma Pediatric Disor... | Total Body Irra... Melphalan Thiotepa Fludarabine Rituximab Etoposide Anti-thymocyte ... Mycophenolate M... Tacrolimus Cord Blood Infu... G-CSF Ex vivo expande... | - 55 Years | M.D. Anderson Cancer Center | |
| Infusion of Expanded Cord Blood T Cells | NCT00972101 | Stem Cell Trans... Leukemia Lymphoma Pediatric Disor... | Total Body Irra... Melphalan Thiotepa Fludarabine Rituximab Etoposide Anti-thymocyte ... Mycophenolate M... Tacrolimus Cord Blood Infu... G-CSF Ex vivo expande... | - 55 Years | M.D. Anderson Cancer Center | |
| CD34+ Transplants for Leukemia and Lymphoma | NCT05565105 | Leukemia, Myelo... Leukemia, Lymph... | Total Body Irra... Thiotepa Cyclophosphamid... Busulfan Melphalan Fludarabine | 18 Years - 74 Years | Baptist Health South Florida |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
